How can collaboration bring new technology to those that need it, faster? Dr. Linda O'Neill, VP of External Innovation at Horizon Therapeutics describes how strategic partnerships can speed the development and deployment of new therapeutics, particularly for autoimmune disorders and potential treatments for rare disease.
Oct 8, 2022 by Dr. Kevin Folta in Talking Biotech
Dr. Linda O'neill, VP of External Innovation at Horizon Therapeutics describes how strategic partnerships can assist biotech startups in moving new therapies through development to deployment. She discusses her company's collaborative approach, and how working together can assist in efforts to navigate the challenging business and regulatory environment.
